.
not coincidentally, maine has a high rate of whooping cough cases � 21.1 per 100,000 people in 2015, compared to 10.3 per 100,000 nationwide.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.